Filter
503
Filtered Results: 503
Text search:
febrile
illness
Featured
Recommendations
77
New Publications
150
Language
Document type
No document type
291
Guidelines
108
Studies & Reports
42
Manuals
21
Fact sheets
14
Training Material
9
Strategic & Response Plan
7
Situation Updates
6
Brochures
2
Infographics
2
Resource Platforms
1
Countries / Regions
India
40
Sierra Leone
16
Liberia
15
Nigeria
14
Global
14
South Africa
13
Uganda
13
Kenya
12
Africa
9
Tanzania
9
Ethiopia
9
Rwanda
8
Philippines
7
Ghana
6
Guinea
5
Latin America and the Carribbean
5
West and Central Africa
5
Bangladesh
5
Nepal
4
Senegal
4
Congo, Democratic Republic of
4
Western and Central Europe
4
East and Southern Africa
4
Myanmar / Burma
4
Lesotho
3
Cameroon
3
Malawi
3
Zimbabwe
3
Mozambique
3
Cambodia
3
South–East Asia Region
3
Namibia
3
Zambia
3
Ukraine
2
Burkina Faso
2
Dominican Republic
2
Germany
2
Papua New Guinea
2
Brazil
2
Mali
2
South Sudan
2
Pakistan
2
Benin
1
Gambia
1
Togo
1
Syria
1
Fiji
1
Peru
1
Mauritania
1
USA
1
Asia
1
Venezuela
1
Saudi Arabia
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Mauritius
1
Eastern Europe
1
Chad
1
Botswana
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
175
Clinical Guidelines
94
Women & Child Health
40
Public Health
27
Key Resources
14
Capacity Building
7
Pharmacy & Technologies
7
Toolboxes
Rapid Response
52
Ebola & Marburg
51
COVID-19
45
NTDs
27
AMR
22
Mental Health
21
Pharmacy
20
HIV
16
Zika
12
Caregiver
10
TB
8
Planetary Health
6
Refugee
5
Disability
3
Health Financing Toolbox
2
NCDs
2
Polio
2
Specific Hazards
1
Natural Hazards
1
Cholera
1
Malaria
1
Conflict
1
Global Health Education
1
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
Revised and expanded version of the Guidelines
BMC Medicine (2015) 13:42 DOI 10.1186/s12916-014-0263-6
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
BMC Medicine 2014, 12:196
http://www.biomedcentral.com/1741-7015/12/196
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
An Indian Primer of Palliative Care
recommended
For medical students and doctors
During the past five decades, the incidence of dengue has increased 30-fold. Some 50–100 million new infections are estimated to occur annually in more than 100 endemic countries, with a documented further spread to previously unaffected areas; every year hundreds of thousands of severe cases ari...
2nd edition, June 2021
J. European Academy of Dermatology and Venereology, 4 August 2014
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
Malaria vaccine: WHO position paper - March 2022
recommended
Weekly Epidemiological Record No 9, 2022, 97, 61–80
This position paper supersedes the 2016 publication, “Malaria vaccine: WHO position paper-2016.”1 It includes the updated WHO recommendations on the wider use of the RTS,S/AS01 vaccine for the reduction of malaria morbidity and mortality in ...
